Orchestra BioMed Holdings reported revenue of $0.09M and net income of -$23.80M for the quarter ended Jun 2026, down 89.5% year over year. This income statement covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||
| Revenue | 0.87M | 0.40M | 1.16M | 1.10M | 1.16M | 0.92M | 0.42M | 0.26M | 0.62M | 0.78M | 0.99M | 0.25M | 0.87M | 0.84M | 0.86M | 30.92M | 0.11M | 0.09M | |||||
| Cost of RevenueCost of Rev | 0.04M | 0.06M | 0.06M | 0.05M | 0.04M | 0.05M | 0.04M | 0.05M | 0.03M | 0.04M | 0.07M | 0.06M | 0.04M | 0.05M | 0.05M | 0.05M | 0.03M | 0.03M | |||||
| Gross Profit | 0.82M | 0.34M | 1.11M | 1.05M | 1.12M | 0.86M | 0.38M | 0.21M | 0.59M | 0.73M | 0.92M | 0.20M | 0.82M | 0.79M | 0.81M | 30.87M | 0.08M | 0.06M | |||||
| Operating items | |||||||||||||||||||||||
| Depreciation & Amortization - TotalDep. & Amort. (Tot) | 0.07M | 0.07M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | ||||||||||||||||
| Research & DevelopmentR&D | 3.47M | 5.03M | 5.90M | 7.54M | 8.25M | 8.50M | 8.56M | 8.51M | 9.11M | 11.13M | 11.60M | 10.97M | 13.48M | 13.85M | 14.03M | 16.82M | 15.78M | 16.59M | |||||
| Selling, General & AdministrativeSG&A | 0.06M | 0.06M | 2.48M | 2.95M | 5.28M | 3.33M | 4.41M | 5.32M | 6.34M | 4.18M | 5.90M | 6.47M | 5.67M | 5.90M | 6.26M | 6.26M | 7.10M | 7.29M | 6.37M | 5.83M | |||
| Restructuring CostsRestructuring | |||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -0.60M | -0.21M | -0.21M | 0.08M | 0.60M | 0.91M | 1.21M | -0.34M | 0.96M | 0.88M | 0.92M | 0.52M | 0.17M | -0.04M | -0.52M | -0.51M | 1.39M | -1.40M | |||||
| Operating ExpensesOpex | 0.06M | 0.06M | 5.99M | 8.04M | 11.23M | 10.93M | 12.71M | 13.87M | 14.94M | 12.74M | 15.04M | 17.64M | 17.33M | 16.93M | 19.79M | 20.16M | 21.17M | 24.16M | 22.19M | 22.44M | |||
| Operating IncomeOp. Inc | -0.09M | -0.09M | -5.13M | -7.63M | -10.07M | -9.83M | -11.54M | -12.96M | -14.52M | -12.48M | -14.42M | -16.86M | -16.34M | -16.68M | -18.92M | -19.33M | -20.31M | 6.75M | -22.08M | -22.36M | |||
| EBIT | -0.09M | -0.09M | -5.13M | -7.63M | -10.07M | -9.83M | -11.54M | -12.96M | -14.52M | -12.48M | -14.42M | -16.86M | -16.34M | -16.68M | -18.92M | -19.33M | -20.31M | 6.75M | -22.08M | -22.36M | |||
| Non-operating items | |||||||||||||||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | -0.22M | 1.73M | -0.31M | -0.17M | -0.03M | -0.06M | 0.29M | -0.29M | 0.00M | -0.01M | 0.12M | -0.18M | -0.01M | -0.02M | 0.03M | 0.01M | -0.10M | -0.04M | |||||
| Interest & Investment IncomeInt & Inv Inc | 0.92M | 1.11M | 1.02M | 0.90M | 0.92M | 0.52M | 0.17M | -0.04M | -0.52M | -0.76M | -0.82M | -1.77M | |||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.68M | -0.01M | -0.04M | 0.32M | |||||||||||||||||||
| Net income details | |||||||||||||||||||||||
| EBT | -0.09M | -0.09M | -5.13M | -7.63M | -10.07M | -9.83M | -11.54M | -12.96M | -13.61M | -11.37M | -13.41M | -15.96M | -15.43M | -16.16M | -18.75M | -19.36M | -20.83M | 5.99M | -22.90M | -24.12M | |||
| Profit After TaxPAT | -0.09M | -0.09M | -5.73M | -7.85M | -10.28M | -9.76M | -10.94M | -12.05M | -13.32M | -12.75M | -13.46M | -15.98M | -15.43M | -16.16M | -18.75M | -19.38M | -20.83M | 6.25M | -20.69M | -23.80M | |||
| Income from Non-Controlling InterestsInc. Minority | |||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -0.09M | -0.09M | -5.13M | -7.63M | -10.07M | -9.83M | -11.54M | -12.96M | -13.61M | -11.37M | -13.41M | -15.96M | -15.43M | -16.16M | -18.75M | -19.36M | -20.83M | 5.99M | -22.90M | -24.12M | |||
| Consolidated Net IncomeConsol Net Inc. | -0.09M | -0.09M | -5.13M | -7.63M | -10.07M | -9.83M | -11.54M | -12.96M | -13.61M | -11.37M | -13.41M | -15.96M | -15.43M | -16.16M | -18.75M | -19.36M | -20.83M | 5.99M | -22.90M | -24.12M | |||
| Income towards Parent CompanyParent Net Inc | -0.09M | -0.09M | -5.13M | -7.63M | -10.07M | -9.83M | -11.54M | -12.96M | -13.61M | -11.37M | -13.41M | -15.96M | -15.43M | -16.16M | -18.75M | -19.36M | -20.83M | 5.99M | -22.90M | -24.12M | |||
| Preferred Dividend PaymentsPref Dividends | -0.04M | 0.32M | |||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -0.09M | -0.09M | -5.13M | -7.63M | -10.07M | -9.83M | -11.54M | -12.96M | -13.61M | -11.37M | -13.41M | -15.96M | -15.43M | -16.16M | -18.75M | -19.36M | -20.83M | 5.99M | -20.66M | -24.08M | |||
| Additional items | |||||||||||||||||||||||
| EPS (Basic) | 0.00 | 0.00 | -0.25 | -0.37 | -0.73 | -0.60 | -0.42 | -0.37 | -0.39 | -0.34 | -0.37 | -0.45 | -0.41 | -0.44 | -0.49 | -0.50 | -0.40 | 0.13 | -0.33 | -0.38 | |||
| EPS (Diluted) | 0.00 | 0.00 | -0.56 | -0.37 | -0.73 | -0.60 | -0.42 | -0.37 | -0.39 | -0.34 | -0.37 | -0.45 | -0.41 | -0.44 | -0.49 | -0.50 | -0.40 | 0.13 | -0.33 | -0.38 | |||
| Shares Outstanding | 20.45M | 20.45M | 20.45M | 20.45M | 13.72M | 16.43M | 27.64M | 34.61M | 35.24M | 33.23M | 35.78M | 35.80M | 37.62M | 36.82M | 38.24M | 38.39M | 52.19M | 47.75M | 62.72M | 63.81M | |||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 20.45M | 20.45M | 9.23M | 20.45M | 13.72M | 16.43M | 27.64M | 34.61M | 35.24M | 33.23M | 35.78M | 35.80M | 37.62M | 36.82M | 38.24M | 38.39M | 52.19M | 47.75M | 62.72M | 63.81M | |||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 20.45M | 20.45M | 20.45M | 20.45M | 13.72M | 16.43M | 31.74M | 35.74M | 35.74M | 35.78M | 35.78M | 35.82M | 37.94M | 38.19M | 38.31M | 38.64M | 56.46M | 57.03M | 58.63M | 60.11M | |||
| EBITDA | -0.09M | -0.09M | -5.13M | -7.63M | -10.07M | -9.83M | -11.54M | -12.96M | -14.52M | -12.48M | -14.35M | -16.79M | -16.27M | -16.59M | -18.84M | -19.25M | -20.23M | 6.75M | -22.08M | -22.36M |